+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

In-vitro Diagnostics Instruments Market 2023-2027

  • PDF Icon

    Report

  • 120 Pages
  • November 2022
  • Region: Global
  • TechNavio
  • ID: 5513994
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The in-vitro diagnostics instruments market is poised to grow by $48.3 billion during 2023-2027, accelerating at a CAGR of 9.18% during the forecast period. The market is driven by the growing geriatric population, demand for personalized medicines, and product launches.

This report on the in-vitro diagnostics instruments market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment.

The in-vitro diagnostics instruments market is segmented as below:

By Product

  • Immunochemistry
  • Clinical Microbiology
  • Molecular diagnostics
  • Others

By End-user

  • Hospitals and diagnostic laboratories
  • Academic and research institutes
  • Home care

By Geography

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the potential opportunities for physician office laboratories (POL) as one of the prime reasons driving the in-vitro diagnostics instruments market growth during the next few years. Also, the leasing of IVD instruments and technological advances in IVD will lead to sizable demand in the market.

This report on the in-vitro diagnostics instruments market covers the following areas:

  • In-vitro diagnostics instruments market sizing
  • In-vitro diagnostics instruments market forecast
  • In-vitro diagnostics instruments market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading in-vitro diagnostics instruments market vendors that include Abbott Laboratories, Beijing Leadman Biochemistry Technology Co. Ltd., bioMerieux SA, Biosino Bio-Technology and Science Inc., CPC Diagnostics Pvt Ltd., DAAN Gene Co. Ltd., Danaher Corp., F. Hoffmann La Roche Ltd., Guangzhou Wondfo Biotech Co. Ltd., Myriad Genetics Inc., Ortho Clinical Diagnostics, Shanghai Kehua Bio-Engineering Co. Ltd., Shenzhen Mindray BioMedical Electronics, Siemens AG, Thermo Fisher Scientific Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., Hologic Inc., QIAGEN NV, and Sysmex Corp. Also, the in-vitro diagnostics instruments market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The analyst presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The analyst's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market by Geography
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Global medical transcription market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global medical transcription market 2017 - 2021 ($ billion)
4.2 Products Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Products Segment 2017 - 2021 ($ billion)
4.3 End-user Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - End-user Segment 2017 - 2021 ($ billion)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Product
6.1 Market segments
Exhibit 30: Chart on Product - Market share 2022-2027 (%)
Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 Immunochemistry - Market size and forecast 2022-2027
Exhibit 34: Chart on Immunochemistry - Market size and forecast 2022-2027 ($ billion)
Exhibit 35: Data Table on Immunochemistry - Market size and forecast 2022-2027 ($ billion)
Exhibit 36: Chart on Immunochemistry - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Immunochemistry - Year-over-year growth 2022-2027 (%)
6.4 Clinical microbiology - Market size and forecast 2022-2027
Exhibit 38: Chart on Clinical microbiology - Market size and forecast 2022-2027 ($ billion)
Exhibit 39: Data Table on Clinical microbiology - Market size and forecast 2022-2027 ($ billion)
Exhibit 40: Chart on Clinical microbiology - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Clinical microbiology - Year-over-year growth 2022-2027 (%)
6.5 Molecular diagnostics - Market size and forecast 2022-2027
Exhibit 42: Chart on Molecular diagnostics - Market size and forecast 2022-2027 ($ billion)
Exhibit 43: Data Table on Molecular diagnostics - Market size and forecast 2022-2027 ($ billion)
Exhibit 44: Chart on Molecular diagnostics - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Molecular diagnostics - Year-over-year growth 2022-2027 (%)
6.6 Others - Market size and forecast 2022-2027
Exhibit 46: Chart on Others - Market size and forecast 2022-2027 ($ billion)
Exhibit 47: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
Exhibit 48: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 49: Data Table on Others - Year-over-year growth 2022-2027 (%)
6.7 Market opportunity by Product
Exhibit 50: Market opportunity by Product ($ billion)
7 Market Segmentation by End-user
7.1 Market segments
Exhibit 51: Chart on End-user - Market share 2022-2027 (%)
Exhibit 52: Data Table on End-user - Market share 2022-2027 (%)
7.2 Comparison by End-user
Exhibit 53: Chart on Comparison by End-user
Exhibit 54: Data Table on Comparison by End-user
7.3 Hospitals and diagnostic laboratories - Market size and forecast 2022-2027
Exhibit 55: Chart on Hospitals and diagnostic laboratories - Market size and forecast 2022-2027 ($ billion)
Exhibit 56: Data Table on Hospitals and diagnostic laboratories - Market size and forecast 2022-2027 ($ billion)
Exhibit 57: Chart on Hospitals and diagnostic laboratories - Year-over-year growth 2022-2027 (%)
Exhibit 58: Data Table on Hospitals and diagnostic laboratories - Year-over-year growth 2022-2027 (%)
7.4 Academic and research institutes - Market size and forecast 2022-2027
Exhibit 59: Chart on Academic and research institutes - Market size and forecast 2022-2027 ($ billion)
Exhibit 60: Data Table on Academic and research institutes - Market size and forecast 2022-2027 ($ billion)
Exhibit 61: Chart on Academic and research institutes - Year-over-year growth 2022-2027 (%)
Exhibit 62: Data Table on Academic and research institutes - Year-over-year growth 2022-2027 (%)
7.5 Home care - Market size and forecast 2022-2027
Exhibit 63: Chart on Home care - Market size and forecast 2022-2027 ($ billion)
Exhibit 64: Data Table on Home care - Market size and forecast 2022-2027 ($ billion)
Exhibit 65: Chart on Home care - Year-over-year growth 2022-2027 (%)
Exhibit 66: Data Table on Home care - Year-over-year growth 2022-2027 (%)
7.6 Market opportunity by End-user
Exhibit 67: Market opportunity by End-user ($ billion)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 69: Chart on Market share by geography 2022-2027 (%)
Exhibit 70: Data Table on Market share by geography 2022-2027 (%)
9.2 Geographic comparison
Exhibit 71: Chart on Geographic comparison
Exhibit 72: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 73: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 74: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 75: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 76: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 77: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 78: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 79: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 81: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 82: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 83: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 85: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 86: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 87: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 89: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 90: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 91: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 China - Market size and forecast 2022-2027
Exhibit 93: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibit 94: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibit 95: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on China - Year-over-year growth 2022-2027 (%)
9.9 Germany - Market size and forecast 2022-2027
Exhibit 97: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 98: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 99: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 100: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.10 UK - Market size and forecast 2022-2027
Exhibit 101: Chart on UK - Market size and forecast 2022-2027 ($ billion)
Exhibit 102: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
Exhibit 103: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 104: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.11 Canada - Market size and forecast 2022-2027
Exhibit 105: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibit 106: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibit 107: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 108: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity by geography
Exhibit 109: Market opportunity by geography ($ billion)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 110: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 111: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 112: Overview on factors of disruption
11.4 Industry risks
Exhibit 113: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 114: Vendors covered
12.2 Market positioning of vendors
Exhibit 115: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 116: Abbott Laboratories - Overview
Exhibit 117: Abbott Laboratories - Business segments
Exhibit 118: Abbott Laboratories - Key news
Exhibit 119: Abbott Laboratories - Key offerings
Exhibit 120: Abbott Laboratories - Segment focus
12.4 Becton Dickinson and Co.
Exhibit 121: Becton Dickinson and Co. - Overview
Exhibit 122: Becton Dickinson and Co. - Business segments
Exhibit 123: Becton Dickinson and Co. - Key news
Exhibit 124: Becton Dickinson and Co. - Key offerings
Exhibit 125: Becton Dickinson and Co. - Segment focus
12.5 Bio Rad Laboratories Inc.
Exhibit 126: Bio Rad Laboratories Inc. - Overview
Exhibit 127: Bio Rad Laboratories Inc. - Business segments
Exhibit 128: Bio Rad Laboratories Inc. - Key news
Exhibit 129: Bio Rad Laboratories Inc. - Key offerings
Exhibit 130: Bio Rad Laboratories Inc. - Segment focus
12.6 bioMerieux SA
Exhibit 131: bioMerieux SA - Overview
Exhibit 132: bioMerieux SA - Product / Service
Exhibit 133: bioMerieux SA - Key news
Exhibit 134: bioMerieux SA - Key offerings
12.7 DAAN Gene Co. Ltd.
Exhibit 135: DAAN Gene Co. Ltd. - Overview
Exhibit 136: DAAN Gene Co. Ltd. - Product / Service
Exhibit 137: DAAN Gene Co. Ltd. - Key offerings
12.8 Danaher Corp.
Exhibit 138: Danaher Corp. - Overview
Exhibit 139: Danaher Corp. - Business segments
Exhibit 140: Danaher Corp. - Key news
Exhibit 141: Danaher Corp. - Key offerings
Exhibit 142: Danaher Corp. - Segment focus
12.9 F. Hoffmann La Roche Ltd.
Exhibit 143: F. Hoffmann La Roche Ltd. - Overview
Exhibit 144: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 145: F. Hoffmann La Roche Ltd. - Key news
Exhibit 146: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 147: F. Hoffmann La Roche Ltd. - Segment focus
12.10 Hologic Inc.
Exhibit 148: Hologic Inc. - Overview
Exhibit 149: Hologic Inc. - Business segments
Exhibit 150: Hologic Inc. - Key news
Exhibit 151: Hologic Inc. - Key offerings
Exhibit 152: Hologic Inc. - Segment focus
12.11 Myriad Genetics Inc.
Exhibit 153: Myriad Genetics Inc. - Overview
Exhibit 154: Myriad Genetics Inc. - Product / Service
Exhibit 155: Myriad Genetics Inc. - Key offerings
12.12 Ortho Clinical Diagnostics
Exhibit 156: Ortho Clinical Diagnostics - Overview
Exhibit 157: Ortho Clinical Diagnostics - Business segments
Exhibit 158: Ortho Clinical Diagnostics - Key offerings
Exhibit 159: Ortho Clinical Diagnostics - Segment focus
12.13 QIAGEN NV
Exhibit 160: QIAGEN NV - Overview
Exhibit 161: QIAGEN NV - Product / Service
Exhibit 162: QIAGEN NV - Key news
Exhibit 163: QIAGEN NV - Key offerings
12.14 Shanghai Kehua Bio Engineering Co. Ltd.
Exhibit 164: Shanghai Kehua Bio Engineering Co. Ltd. - Overview
Exhibit 165: Shanghai Kehua Bio Engineering Co. Ltd. - Product / Service
Exhibit 166: Shanghai Kehua Bio Engineering Co. Ltd. - Key offerings
12.15 Siemens AG
Exhibit 167: Siemens AG - Overview
Exhibit 168: Siemens AG - Business segments
Exhibit 169: Siemens AG - Key news
Exhibit 170: Siemens AG - Key offerings
Exhibit 171: Siemens AG - Segment focus
12.16 Sysmex Corp.
Exhibit 172: Sysmex Corp. - Overview
Exhibit 173: Sysmex Corp. - Business segments
Exhibit 174: Sysmex Corp. - Key offerings
Exhibit 175: Sysmex Corp. - Segment focus
12.17 Thermo Fisher Scientific Inc.
Exhibit 176: Thermo Fisher Scientific Inc. - Overview
Exhibit 177: Thermo Fisher Scientific Inc. - Business segments
Exhibit 178: Thermo Fisher Scientific Inc. - Key news
Exhibit 179: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 180: Thermo Fisher Scientific Inc. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 181: Inclusions checklist
Exhibit 182: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 183: Currency conversion rates for US$
13.4 Research methodology
Exhibit 184: Research methodology
Exhibit 185: Validation techniques employed for market sizing
Exhibit 186: Information sources
13.5 List of abbreviations
Exhibit 187: List of abbreviations

Executive Summary

The analyst recognizes the following companies as the key players in the global in-vitro diagnostics instruments market: Abbott Laboratories, Beijing Leadman Biochemistry Technology Co. Ltd., bioMerieux SA, Biosino Bio-Technology and Science Inc., CPC Diagnostics Pvt Ltd., DAAN Gene Co. Ltd., Danaher Corp., F. Hoffmann La Roche Ltd., Guangzhou Wondfo Biotech Co. Ltd., Myriad Genetics Inc., Ortho Clinical Diagnostics, Shanghai Kehua Bio-Engineering Co. Ltd., Shenzhen Mindray BioMedical Electronics, Siemens AG, Thermo Fisher Scientific Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., Hologic Inc., QIAGEN NV, and Sysmex Corp.

Commenting on the report, one of the report's analysts said: 'The latest trend gaining momentum in the market is potential opportunities for physician office laboratories (POL).'

According to the report, one of the major drivers for this market is the growing geriatric population.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Beijing Leadman Biochemistry Technology Co. Ltd.
  • bioMerieux SA
  • Biosino Bio Technology and Science Inc.
  • CPC Diagnostics Pvt Ltd.
  • DAAN Gene Co. Ltd.
  • Danaher Corp.
  • F. Hoffmann La Roche Ltd.
  • Guangzhou Wondfo Biotech Co. Ltd.
  • Myriad Genetics Inc.
  • Ortho Clinical Diagnostics
  • Shanghai Kehua Bio Engineering Co. Ltd.
  • Shenzhen Mindray BioMedical Electronics
  • Siemens AG
  • Thermo Fisher Scientific Inc.
  • Becton Dickinson and Co.
  • Bio Rad Laboratories Inc.
  • Hologic Inc.
  • QIAGEN NV
  • Sysmex Corp.